(Q37138017)

18 August 2017

1 reference

title

Autoimmunity in atherosclerosis: a protective response losing control? (English)

1 reference

18 August 2017

1 reference

J Nilsson

1

1 reference

18 August 2017

G K Hansson

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

Journal of Internal Medicine

18 August 2017

1 reference

18 August 2017

263

1 reference

18 August 2017

5

1 reference

18 August 2017

464-478

1 reference

Inflammation, atherosclerosis, and coronary artery disease

18 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Cytokines in atherosclerosis: pathogenic and regulatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

The immune response in atherosclerosis: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Innate and acquired immunity in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Regulatory T cells: friend or foe in immunity to infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Atherosclerosis. the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Oxidized phospholipids as modulators of inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Low density lipoprotein undergoes oxidative modification in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Autoimmune and inflammatory mechanisms in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Structure and function: heat shock proteins and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

DNA damage and repair in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Phagocytosis of apoptotic cells and immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Autoimmunity versus tolerance: can dying cells tip the balance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Toll-like receptors and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Pattern recognition receptors: doubling up for the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Innate immunity, macrophage activation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Inferences, questions and possibilities in Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

How Toll-like receptors signal: what we know and what we don't know

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Modulation of atherosclerosis in mice by Toll-like receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Endogenous ligands of Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

TLR4 links innate immunity and fatty acid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Dendritic cells and their involvement in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Cell biology of antigen processing in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Recent advances in antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Apolipoprotein-mediated pathways of lipid antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Medium- and large-vessel vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Demonstration of immunoglobulin in the neighbourhood of advanced atherosclerotic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

The interface between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Requirement for CD154 in the progression of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

CD1d-dependent activation of NKT cells aggravates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Antigen-induced regulatory T cells in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Regulatory T-cell immunity in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Timing affects the efficacy of LDL immunization on atherosclerotic lesions in apo E (-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

21 January 2018

Marginal-zone B cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Immune therapy for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Immunomodulation with human recombinant autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

Natural regulatory T cells control the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01945.X

10.1111/J.1365-2796.2008.01945.X

21 January 2018

Identifiers

DOI

1 reference

release_ylnh6qlmovckpgo25i454eekke

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ylnh6qlmovckpgo25i454eekke

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference